CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- SC 13D/A Stake Beneficial Ownership Report
- PRE 14C Other PRE 14C
- 8-K Event Material agreement · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 8-K Event New debt or obligation · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift EVP Liver Cirrhosis Programs gave 1,000 shares (gift)
- 10-Q Report Quarterly Report
- 4 Grant or award President & CEO acquired 21,710 shares (grant or award)
- 4 Open-market buy CFO bought 2,000 shares at $5.40 ($10,798)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
Page 13 of 26 · 511 filings